A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...
WASHINGTON (AP) — Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy. Sarepta reported the ...
Twenty-six years ago today, on Sept. 17, a teenager who had received an experimental gene therapy died. His death led to needed changes in the clinical trial process while also spurring skepticism ...
The death of a patient in a trial of an experimental gene therapy casts new shadows over a technology once seen as the future of the drug industry. Rocket Pharmaceuticals, a New Jersey-based biotech, ...
The death of a 5-year-old in a hyperbaric chamber in Michigan has prompted calls for more oversight of hyperbaric oxygen therapy in the largely unsupervised wellness industry before another tragedy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results